Study ID: TV46000-CNS-30072 | 03503318 | 2018-001619-65

Study Title

Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Patients With Schizophrenia

Teva Identifier

TV46000-CNS-30072 | 03503318 | 2018-001619-65

ClinicalTrials.gov Identifier

NCT03503318

Study Status

Completed

Trial Condition(s)

Schizophrenia

Interventions

Drug: TV-46000 - A | Drug: TV-46000 - B | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements

Gender

Female, Male

Age Range

13 Years to 65 Years

Trial Duration

April 27, 2018 - December 3, 2020

Phase

Phase 3

Study Type

Interventional